Development of Brain Metastases in Patients With Non–Small Cell Lung Cancer and No Brain Metastases at Initial Staging Evaluation: Cumulative Incidence and Risk Factor Analysis-Reference-Cited by-同舟云学术

Development of Brain Metastases in Patients With Non–Small Cell Lung Cancer and No Brain Metastases at Initial Staging Evaluation: Cumulative Incidence and Risk Factor Analysis

Published:2021-11 Issue:5 Volume:217 Page:1184-1193
ISSN:0361-803X
Container-title:American Journal of Roentgenology
language:en
Short-container-title:American Journal of Roentgenology

Author:

Kim Minjae¹,Suh Chong Hyun¹,Lee Sang Min¹,Park Ji Eun¹,Kim Ho Cheol²,Kim Seon-Ok³,Aizer Ayal A.⁴,Yanagihara Ted K.⁵,Bai Harrison X.⁶,Guenette Jeffrey P.⁷,Huang Raymond Y.⁷,Kim Ho Sung¹

Affiliation:

1. Department of Radiology and Research Institute of Radiology, Asan Medical Center, University of Ulsan College of Medicine, Olympic-ro 33, Seoul 05505, Republic of Korea

2. Department of Pulmonology and Critical Care Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea

3. Department of Clinical Epidemiology and Biostatistics, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea

4. Department of Radiation Oncology, Brigham and Women's Hospital, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA

5. Department of Radiation Oncology, University of North Carolina at Chapel Hill, Chapel Hill, NC

6. Department of Diagnostic Imaging, Rhode Island Hospital and Warren Alpert Medical School of Brown University, Providence, RI

7. Division of Neuroradiology, Brigham and Women's Hospital, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA

Publisher

American Roentgen Ray Society

Subject

Radiology Nuclear Medicine and imaging,General Medicine

Link

https://www.ajronline.org/doi/pdf/10.2214/AJR.21.25787

Reference30 articles.

1. Incidence Proportions of Brain Metastases in Patients Diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System

2. Incidence of brain metastases in a cohort of patients with carcinoma of the breast, colon, kidney, and lung and melanoma

3. EGFR Mutation and Brain Metastasis in Pulmonary Adenocarcinomas

4. Extended Survival and Prognostic Factors for Patients With ALK-Rearranged Non–Small-Cell Lung Cancer and Brain Metastasis

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of brain metastases in non-small-cell lung cancer: high-risk features;CNS Oncology;2024-09-12

2. AuNPs/DNAzyme/siRNA three-dimensional nanomotor for CEACAM6 RNA detection in cerebrospinal fluid and gene therapy of NSCLC;Chemical Engineering Journal;2024-09

3. Performance status improvement and advances in systemic treatment after brain metastases resection: a retrospective single-center cohort study of non-small cell lung cancer patients;BMC Cancer;2024-08-21

4. MRI radiomics predicts the efficacy of EGFR-TKI in EGFR-mutant non-small-cell lung cancer with brain metastasis;Clinical Radiology;2024-07

5. The clinical, molecular, and therapeutic implications of time from primary diagnosis to brain metastasis in lung and breast cancer patients;Cancer Medicine;2024-06